Sodium dichloroacetate Recruiting Phase 2 Trials for Glioblastoma Multiforme (GBM) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT05120284Trial of Dichloroacetate (DCA) in Glioblastoma Multiforme (GBM)